Together We Build: Rentschler Biopharma Celebrates Milford Site Progress and Growth Since US Expansion

Apr 03, 2026

Celebrating the journey of progress and evolution at our Milford, MA site

Posted by Rentschler Biopharma Inc

https://www.linkedin.com/posts/rentschler-biopharma_press-release-together-we-build-in-milford-activity-7442194807428628482-J-6C?utm_source=social_share_send&utm_medium=member_desktop_web&rcm=ACoAAAGBIr0BAP_3y98KQZnfRhIRQ-kqOWXe0fc

Last Week, we gathered to celebrate the journey of progress and evolution at our Milford, MA site. Since 2019, our facility has transformed into a state-of-the-art, multi-product site, adding 22,000 square feet of manufacturing cleanroom space, significantly expanding our global cGMP capacity. This expansion is the largest in our 150-year history and underscores our commitment to excellence and innovation. 

Our “Together We Build” event was a testament to the hard work and dedication of our team and our deep connection to the Milford, MA community. This celebration was a chance to gather and share gratitude for all those, internal and external, who helped make our site evolution possible. 

Uwe Buecheler, PhD, our Interim CEO, commented: 
“At Rentschler Biopharma, we are committed to advancing medicine to save lives – together. ‘Together We Build’ reflects how we support our clients by delivering reliably at every step of their molecule’s journey. With our expanded U.S. footprint, we combine deep technical expertise, a proven track record of high‑quality execution, and the long‑term stability of our family‑owned company. The progress we are seeing in Milford is the result of years of purposeful investment and the dedication of an exceptional team. This site is an integral part of our global network, enabling seamless continuity from early development through commercial supply. We will continue building on this strong foundation, together with our clients and our people, to bring innovative therapies to patients who need them.” 

Tom Roberts, our President of Rentschler Biopharma Inc. and General Manager U.S., added: 
“Our Milford site has entered a new phase of growth. We are onboarding diverse client programs, advancing late‑stage projects, and supporting partners from across the world who trust us with their most critical molecules. What sets us apart is our hands‑on scientific expertise and the way our teams work side‑by‑side with clients to design tailored solutions that keep programs moving forward with speed and confidence. I am grateful to our entire team for their dedication and hard work as we collaborate with our clients to transform innovative ideas into life-saving biopharmaceuticals and enable rapid market access to new treatments.” 

For more details read our press release: https://lnkd.in/d-5sp8cQ

Thank you to everyone who has been part of this journey. Together, we are building a brighter future for biopharmaceutical manufacturing. 

hashtagRentschlerBiopharma hashtagCDMO hashtagReliabilityYouCanTrust hashtagTogetherWeBuild

See all Member News